Management of community-associated methicillin-resistant Staphylococcus aureus infections in children (Q33264579)

24 July 2017

1 reference

title

Management of community-associated methicillin-resistant Staphylococcus aureus infections in children (English)

1 reference

methicillin-resistant Staphylococcus aureus

24 July 2017

0 references

Staphylococcus aureus

1 reference

Jennifer Le

1

1 reference

PubMed ID

17125437

24 July 2017

Jay M Lieberman

series ordinal

2

1 reference

PubMed ID

17125437

24 July 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

24 July 2017

1 reference

24 July 2017

26

1 reference

24 July 2017

12

1 reference

24 July 2017

1758-1770

1 reference

The changing epidemiology of Staphylococcus aureus?

24 July 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Methicillin-resistant Staphylococcus aureus disease in three communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Infection in California Jails

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Methicillin-resistant Staphylococcus aureus infection in the Texas prison system

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Origins of community strains of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Failure of Clindamycin Treatment of Methicillin-Resistant Staphylococcus aureus Expressing Inducible Clindamycin Resistance In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Purpura fulminans due to Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Trimethoprim-sulfamethoxazole revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Drug-induced thrombocytopenia: a systematic review of published case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Arthralgias and myalgias related to quinupristin-dalfopristin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Safety and efficacy of quinupristin/dalfopristin for treatment of invasive Gram-positive infections in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Activity of linezolid against Gram-positive cocci possessing genes conferring resistance to protein synthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Safety and tolerability of linezolid in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Hematologic effects of linezolid in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Hematologic effects of linezolid: summary of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Serotonin syndrome and linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Enterococcus faecalis resistant to linezolid: case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid resistance in clinical isolates of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid resistance in a clinical isolate of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid resistance since 2001: SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Daptomycin disrupts membrane potential in growing Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Once-daily dosing in dogs optimizes daptomycin safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Safety profile of quinolone antibiotics in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Treatment of community-associated methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid versus vancomycin in the treatment of known or suspected resistant Gram-positive infections in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Linezolid for the treatment of complicated skin and skin structure infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Intrapulmonary pharmacokinetics of linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Appropriate antimicrobial therapy for community-acquired methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Dinosaurs, methicillin-resistant Staphylococcus aureus, and infection control personnel: survival through translating science into prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

Effect of rifampin and bacitracin on nasal carriers of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.12.1758

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.12.1758

1 reference

24 July 2017

1 reference

PubMed ID

17125437